Related by context. Frequent words. (Click for all words.) 59 antitumor activity 57 engraftment 56 immune responses 55 #ME# 55 neutralizing antibody 55 decitabine 55 antiviral activity 55 liver metastases 55 HuMax CD# 54 HGS ETR1 54 antibody responses 54 PXD# 54 IMC A# 54 TRIOLEX 54 axitinib 54 viral suppression 53 TroVax 53 hematopoietic 53 neoadjuvant chemotherapy 53 dose cohorts 53 CoFactor 53 ProLindac 53 interferon beta 53 Phase 2a trial 52 PROMACTA 52 EpCAM 52 GVAX 52 oral bioavailability 52 bioactivity 52 Revimmune 52 G CSF 52 mAbs 52 EGFRvIII 52 CYT# 52 RECIST criteria 51 PGE2 51 mediated immunity 51 CTGF 51 secondary efficacy endpoints 51 Neuradiab 51 humoral 51 VLPs 51 SUTENT 51 tesmilifene 51 Th# cells 51 tamoxifen therapy 51 neutralizing antibodies 51 tumor progression 50 INCB# [002] 50 cytotoxicity 50 mg kg dose 50 preclinical models 50 immunomodulator 50 GRN#L 50 murine 50 denufosol 50 panitumumab 50 subgroup analyzes 50 antitumor 50 elesclomol 50 vivo 50 dose escalation 50 reperfusion injury 50 tumor antigens 50 TELCYTA 50 pharmacokinetic profile 50 immunosuppression 50 cardiac dysfunction 50 immunogenicity 49 RANKL 49 CMV infection 49 hepatocytes 49 mRNA expression 49 cellular pathways 49 AP# [003] 49 NeuroVax TM 49 MGCD# [001] 49 Phase 1b trial 49 GM CSF 49 infarct size 49 MultiStem 49 MOZOBIL 49 Phase 2b trial 48 FVIII 48 vascularization 48 viral vector 48 Phase 1b 48 neoadjuvant 48 clusterin 48 VIDAZA 48 hepatocyte 48 ozarelix 48 immunologic 48 ES cells 48 inhibitory activity 48 tolerability 48 cytogenetic response 48 Phase III trials 48 sustained virologic response 48 NKT cells 48 HDAC inhibitors